J05AP Antivirals for treatment of HCV infections

Place in the ATC system

1. J Antiinfectives for systemic use 1,101 drugs
   1. J05 Antivirals for systemic use 246 drugs
      1. J05A Direct acting antivirals 246 drugs
         1. J05AP Antivirals for treatment of HCV infections 16 drugs
            1. J05AP01 Ribavirin 3 drugs
            2. J05AP02 Telaprevir 1 drug
            3. J05AP03 Boceprevir 1 drug
            4. J05AP05 Simeprevir 1 drug
            5. J05AP06 Asunaprevir 1 drug
            6. J05AP07 Daclatasvir 1 drug
            7. J05AP08 Sofosbuvir 1 drug
            8. J05AP51 Sofosbuvir and ledipasvir 1 drug
            9. J05AP52 Dasabuvir, ombitasvir, paritaprevir and ritonavir 1 drug
            10. J05AP53 Ombitasvir, paritaprevir and ritonavir 1 drug
            11. J05AP54 Elbasvir and grazoprevir 1 drug
            12. J05AP55 Sofosbuvir and velpatasvir 1 drug
            13. J05AP56 Sofosbuvir, velpatasvir and voxilaprevir 1 drug
            14. J05AP57 Glecaprevir and pibrentasvir 1 drug

Active ingredients of the class

• Asunaprevir 1 drug
• Boceprevir 1 drug
• Daclatasvir (daclatasvir dihydrochloride) 1 drug
• Dasabuvir (dasabuvir sodium monohydrate) 1 drug
• Elbasvir 1 drug
• Glecaprevir 1 drug
• Grazoprevir 1 drug
• Ledipasvir 1 drug
• Ombitasvir 2 drugs
• Paritaprevir 2 drugs
• Pibrentasvir 1 drug
• Ribavirin 3 drugs
• Ritonavir 2 drugs
• Simeprevir (simeprevir sodium) 1 drug
• Sofosbuvir 4 drugs
• Telaprevir 1 drug
• Velpatasvir 2 drugs
• Voxilaprevir 1 drug

Drugs in the class and its subclasses

Other classes of the same level

• J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
• J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
• J05AE Protease inhibitors, direct acting antivirals 28 drugs
• J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
• J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
• J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
• J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
• J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
• J05AX Other antivirals 13 drugs

Other names of the drug class

• Czech: J05AP Antivirotika k léčbě infekce HCV
• English (United Kingdom): J05AP Antivirals for treatment of HCV infections
• German: J05AP Antivirale Mittel zur Behandlung von Hepatitis C Infektionen
• German (Austria): J05AP Antivirale Mittel zur Behandlung von Hepatitis C Infektionen
• Italian: J05AP ANTIVIRALI PER IL TRATTAMENTO DELL'INFEZIONE DA HCV
• Polish: J05AP Antywirotyki do leczenia zakażenia hcv
• Turkish: J05AP HCV enfeksiyonlarının tedavisi için antiviraller
• German (Switzerland): J05AP Antivirale Mittel zur Behandlung von Hepatitis C Infektionen
• Italian (Switzerland): J05AP Antivirali per IL trattamento dell'infezione da hcv